2,115
Views
2
CrossRef citations to date
0
Altmetric
Short Report

Human papillomavirus prevalence, genomic diversity and related risk factors in HIV-positive women from a countryside city in the state of Rio de Janeiro

ORCID Icon, ORCID Icon, ORCID Icon, , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 838-844 | Received 25 Feb 2020, Accepted 17 Jul 2020, Published online: 22 Sep 2020

References

  • Bansal A, Singh MP, Rai B. Human papillomavirus-associated cancers: A growing global problem. International Journal of Applied and Basic Medical Research. 2016 Apr-Jun;6(2):84–89. PMID: 27127735; PMCID: PMC 4830161. doi:10.4103/2229-516X.179027.
  • Berry JM, Palefsky JM. A review of human papillomavirus vaccines: from basic science to clinical trials. Front Biosci. 2003 May 1;8:s333–45. doi:10.2741/1003. PMID: 12700045.
  • de Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur HH. Classification of papillomaviruses. Virology PMID: 15183049. 2004 Jun 20;324(1):17–27. doi:10.1016/j.virol.2004.03.033.
  • Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de, Sanjosé S ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 17 June 2019.[ Accessed on 2019, december 15] https://www.hpvcentre.net/statistics/reports/XWX.pdf
  • Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, et al. Global burden of human papillomavirus and related diseases. Vaccine PMID: 23199955. 2012 Nov 20;30(Suppl 5):F12–23. doi:10.1016/j.vaccine.2012.07.055.
  • Association Hospital Moinhos de Vento. Epidemiological Study on the National Prevalence of HPV Infection (POP-Brazil): preliminary results. Porto Alegre: Moinhos de Vento Hospital Association; 2017. [ Accessed on 2019, march 3] https://sboc.org.br/images/downloads/LIVRO-POP.pdf
  • Ministry of Health of Brazil - National Cancer Institute (2018). Estimation of Cancer in Brazil. [ Accessed on 2019, december 15] https://www.inca.gov.br/numeros-de-cancer
  • Dreyer G. Clinical implications of the interaction between HPV and HIV infections. Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:95–106.. DOI:10.1016/j.bpobgyn.2017.08.011. Epub 2017 Sep 6. PMID: 28958633.
  • Bragagnolo AL, Eli D, Haas P. Human Papillomavirus (HPV). RBAC- Brazilian Journal of Clinical Analysis. 2010;42(2):91–96. 2019, December 15. http://www.rbac.org.br/wp-content/uploads/2016/08/RBAC_Vol42_n2-Completa.pdf.
  • Sharp M & Dohme (MSD®). Nonavalent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58,) Recombinant Vaccine. Internationally known as “Gardasil”. Product prescribing information, 2020. [ Accessed on 2020, April 26] https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf
  • Brazilian Ministry of Health. Health Surveillance Secretariat. Communicable Disease Surveillance Department. General Coordination of the National Immunization Program (CGPNI). Human Quadrivalent Papillomavirus Vaccine Technical Report, Brasilia.; Biblioteca Virtual en Salud BIREME/OPS/OMS, sep 2015 [ Accessed on. 2018, September 20] http://www.saude.gov.br/images/PDF/2015/junho/26/Informe-T–cnico-Vacina-HPV-2015-FINAL.PDF
  • Brazilian Institute of Statistical Geography - IBGE. Demographic Census. Estimated population of 2019, Campos dos Goytacazes [ Accessed on 2019, December 15]. https://cidades.ibge.gov.br/brasil/rj/campos-dos-goytacazes/panorama
  • Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual (3 Volume Set) 2nd Edition. Spector DL, Goldman RD, Leinwand L, Edited by. Cold Spring Harbor Laboratory Press, New York, 1998. ISBN: 9780879695774.
  • Bauer HM, Greer CE, Manos MM. Determination of genital HPV infection using consensus PCR. In: Herrington CS, McGee JOD, editors. Diagnositic molecular pathology: a practical approach. Oxford (United Kingdom): Oxford University Press; 1992. p. 131–52.
  • Afonso LA, Moyses N, Alves G, Ornellas AA, Passos MR, Oliveira Ldo H, Cavalcanti SM. Prevalence of human papillomavirus and Epstein-Barr virus DNA in penile cancer cases from Brazil. Mem Inst Oswaldo Cruz. 2012 Feb;107(1):18–23. PMID: 22310531. doi:10.1590/s0074-02762012000100003.
  • Dean AG, Sullivan KM, Soe MM OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.2. Updated November 2014 [Accessed on 2017, may 05] http://www.OpenEpi.com
  • Miranda AE, Silveira MF, Travassos AG, Tenório T, Val ICC, Lannoy L, Mattos JHS, Carvalho NS. High-risk papillomavirus infection among women living with human Immunodeficiency virus: brazilian multicentric study. J Med Virol. 2017 Dec;89(12):2217–23. DOI:10.1002/jmv.24906. Epub 2017 Sep 28. PMID: 28771777.
  • AE M, Lucena-Silva N, RG G, Welkovic S, Barboza A, ML M, Maruza M, Tenório T, RA X. Prevalence of human papillomavirus infection, distribution of viral types and risk factors in cervical samples from human immunodeficiency virus-positive women attending three human immunodeficiency virus-acquired immune deficiency syndrome reference centres in northeastern Brazil. Mem Inst Oswaldo Cruz. 2014 Sep;109(6):738–47. DOI:10.1590/0074-0276140070. Epub 2014 Aug 22. PMID: 25317701; PMCID: PMC4238765.
  • Ortiz AP, Tamayo V, Scorsone A, Soto-Salgado M, Febo I, Piovanetti P, Venegas-Ríos HL, Yamamura Y, Zorrilla C Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women. Version 2. Papillomavirus Res. 2017 Dec;4:39–44. doi: 10.1016/j.pvr.2017.06.006. Epub 2017 Jun 19. PMID: 29179868; PMCID: PMC5791754.
  • Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IA, Odberg Pettersson K. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J. 2014 Jan 15;11:5. doi:10.1186/1743-422X-11-5. PMID: 24433568; PMCID: PMC3896716.
  • Chakravarty J, Chourasia A, Thakur M, Singh AK, Sundar S, Agrawal NR. Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India. Indian J Med Res. 2016 Jan;143(1):79–86. PMID: 26997018; PMCID: PMC4822373. doi:10.4103/0971-5916.178614.
  • Silva KC, Rosa ML, Moyse N, Afonso LA, Oliveira LH, Cavalcanti SM. Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2009 Sep;104(6):885–91. PMID: 19876561. doi:10.1590/s0074-02762009000600011.
  • Travassos AG, Netto E, Xavier-Souza E, Nobrega I, Adami K, Timbó M, Abbehussen K, Fernandes S, Duran C, Haguihara T, et al.Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women. PLoS One. 2017;12(10):e0185423. Published. 2017 Oct 5. doi: 10.1371/journal.pone.0185423.
  • Ene L, Voinea C, Stefanescu C, Sima D, Duiculescu D, Mehta SR. Cervical HPV infection in Romanian women infected with HIV during early childhood. Int J STD AIDS. 2016 Oct;27(12):1079–85. DOI:10.1177/0956462415608333. Epub 2015 Sep 24. PMID: 26404111; PMCID: PMC5482901. .
  • Teixeira MF, Sabidó M, Leturiondo AL, de Oliveira Ferreira C, Torres KL, Benzaken AS. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas. Virol J PMID: 29454382; PMCID: PMC5816532. 2018 Feb 17;15(1):36. doi:10.1186/s12985-018-0942-6.
  • Tso FK, Rodrigues CL, Levi JE, Mattosinho de Castro Ferraz MG, Speck NM, Ribalta JC. HPV infection-associated anogenital cyto-colpo-histological findings and molecular typing in HIV-positive women. Genet Mol Res PMID: 26782408. 2015 Dec 21;14(4):17630–40. doi:10.4238/2015.December.21.36.
  • Castilho JL, Levi JE, Luz PM, Cambou MC, Vanni T, de Andrade A, Derrico M, Veloso VG, Grinsztejn B, Friedman RK. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil. BMC Cancer. 2015 Jun 23;15:478. doi:10.1186/s12885-015-1486-4. PMID: 26100400; PMCID: PMC4477502.
  • Adler D, Wallace M, Bennie T, Abar B, Sadeghi R, Meiring T, Williamson AL, Bekker LG. High risk human papillomavirus persistence among HIV-infected young women in South Africa. Int J Infect Dis. 2015 Apr;33:219–21. . DOI:10.1016/j.ijid.2015.02.009. Epub 2015 Feb 17. PMID: 25697074; PMCID: PMC4397173.
  • Mujuni F, Mirambo MM, Rambau P, Klaus K, Andreas M, Matovelo D, Majigo M, Kasang C, Mshana SE. Variability of high risk HPV genotypes among HIV infected women in Mwanza, Tanzania- the need for evaluation of current vaccine effectiveness in developing countries. Infect Agent Cancer. 2016 Aug 19;11:49. doi:10.1186/s13027-016-0097-2. PMID: 27547239; PMCID: PMC4991109.
  • Thorsteinsson K, Storgaard M, Katzenstein TL, Ladelund S, Rönsholt FF, Johansen IS, Pedersen G, Gaardsting A, Nielsen LN, Bonde J, et al. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study. J Clin Virol. 2018 Aug;105:64–71. . DOI:10.1016/j.jcv.2018.05.010. Epub 2018 May 25. PMID: 29906660.
  • Fusco FM, Vichi F, Bisanzi S, Sani C, Degli Esposti A, Blè C, Rossi R, Pompeo G, Carozzi F, Blanc P. HPV infection and pre-neoplastic cervical lesions among 321 HIV+ women in Florence, Italy, 2006-2016: prevalence and associated factors. New Microbiol. 2018 Oct;41(4):268–73. Epub 2018 Sep 25. PMID: 30252922.